The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks finish higher after very quiet Monday

Mon, 12th Feb 2024 17:11

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

The FTSE 100 index edged up by 0.02% to reach 7,573.69 points, while the FTSE 250 saw a more notable rise of 0.74% to settle at 19,203.93 points.

In currency markets, sterling was last up 0.05% on the dollar to trade at $1.2634, while it rose 0.09% against the euro to change hands at €1.1721.

"The new week has begun with gains for stocks, though once again the FTSE 100 has been left out thanks to weakness in its heavyweight pharmaceutical stocks," said IG chief market analyst Chris Beauchamp.

"European indices have led the way today, and despite fears of broad-based weakness in the eurozone economy both the DAX and CAC 40 continue to hover near record highs."

Beauchamp added that Tuesday's consumer price index reading in the US was looking to be the main event of the week.

"Price growth is expected to keep slowing towards the Fed's target, so investors will be hoping for a bigger-than-expected drop in order to provide the foundations of a rally to fresh record highs for US indices."

UKCP jumps on offer from Tritax, GSK slips

On London's equity markets, UK Commercial Property REIT jumped 4.83% following news of a potential acquisition by Tritax Big Box in a deal valued at £924m.

Tritax, which itself closed down 4%, said it had offered 0.444 new Tritax shares for every UKCP share, leaving it with 76.7% of the merged group and UKCM shareholders with the remainder.

It represented a 10.8% premium to UKCP's closing share price of 64.2 pence per share on 9 February.

Elsewhere, Mike Ashley's retail conglomerate Frasers Group rose 4.98% after announcing an £80m share buyback initiative.

SSP Group saw a modest gain of 1.07% following its acquisition of Airport Retail Enterprises in Australia.

Anglo American climbed 2.88% after signing a memorandum of understanding with Finnish Minerals Group to support Finland's battery strategy.

Finnish Minerals Group is a holding and development company that manages the Finnish Government's mining industry shareholdings and supports the development of the Finnish battery value chain.

Jupiter Fund Management leapt 7% after receiving an upgraded rating to 'neutral' from BNP Paribas Exane.

On the downside, GSK dipped 2.02% despite confirming the US FDA had granted fast track designation for its investigational drug, bepirovirsen, aimed at treating chronic hepatitis B.

Ashmore Group faced a 3.22% drop after JPMorgan maintained its 'underweight' rating on the stock and adjusted the price target downwards, citing concerns about the extent of the recent re-rating.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,573.69 0.02%

FTSE 250 (MCX) 19,203.93 0.74%

techMARK (TASX) 4,388.36 -0.32%

FTSE 100 - Risers

Burberry Group (BRBY) 1,335.50p 5.07%

Frasers Group (FRAS) 822.50p 4.98%

Ocado Group (OCDO) 536.80p 4.60%

Fresnillo (FRES) 493.40p 3.50%

Anglo American (AAL) 1,751.60p 2.88%

Endeavour Mining (EDV) 1,323.00p 2.88%

Glencore (GLEN) 394.25p 2.39%

Antofagasta (ANTO) 1,679.00p 2.25%

Beazley (BEZ) 578.50p 2.21%

Land Securities Group (LAND) 641.80p 2.13%

FTSE 100 - Fallers

Rolls-Royce Holdings (RR.) 309.10p -2.83%

AstraZeneca (AZN) 9,501.00p -2.66%

GSK (GSK) 1,626.40p -2.02%

Melrose Industries (MRO) 594.00p -1.49%

NATWEST GROUP (NWG) 207.70p -1.42%

Sage Group (SGE) 1,175.00p -1.34%

Compass Group (CPG) 2,200.00p -1.21%

Intertek Group (ITRK) 4,416.00p -1.14%

DCC (CDI) (DCC) 5,716.00p -0.90%

Croda International (CRDA) 4,927.00p -0.87%

FTSE 250 - Risers

Jupiter Fund Management (JUP) 86.00p 8.31%

TUI AG Reg Shs (DI) (TUI) 579.50p 5.65%

UK Commercial Property Reit Limited (UKCM) 67.30p 4.83%

Watches of Switzerland Group (WOSG) 410.00p 4.11%

Future (FUTR) 735.00p 3.90%

Direct Line Insurance Group (DLG) 167.50p 3.59%

Dr. Martens (DOCS) 87.85p 3.54%

W.A.G Payment Solutions (WPS) 88.00p 3.53%

Moneysupermarket.com Group (MONY) 252.60p 3.36%

Crest Nicholson Holdings (CRST) 226.00p 3.29%

FTSE 250 - Fallers

Tritax Big Box Reit (BBOX) 153.80p -4.00%

Ashmore Group (ASHM) 222.20p -3.22%

Baltic Classifieds Group (BCG) 228.00p -2.56%

Hilton Food Group (HFG) 791.00p -1.62%

TBC Bank Group (TBCG) 2,895.00p -1.53%

Octopus Renewables Infrastructure Trust (ORIT) 77.80p -1.52%

The Renewables Infrastructure Group Limited (TRIG) 99.80p -1.38%

Trustpilot Group (TRST) 185.70p -1.38%

Inchcape (INCH) 665.50p -1.33%

Diversified Energy Company (DEC) 907.50p -1.31%

More News
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.